Intravenous Injection of Myelin Oligodendrocyte Glycoprotein-coated PLGA Microparticles Have Tolerogenic Effects in Experimental Autoimmune Encephalomyelitis

Intravenous Injection of Myelin Oligodendrocyte Glycoprotein-coated PLGA Microparticles Have Tolerogenic Effects in Experimental Autoimmune Encephalomyelitis

The abnormal function of the T lymphocytes causes a range of autoimmune diseases, particularly multiple sclerosis; hence, several methods have been used to treat these disorders through the induction of antigen-specific tolerance in T cells. The present study aims to use a simple and low-cost method...

Full description

Bibliographic Details
Main Authors:	Mehrdad Gholamzad, Masoumeh Ebtekar, Mehdi Shafiee Ardestani
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2017-06-01
Series:	Iranian Journal of Allergy, Asthma and Immunology
Subjects:	Experimental autoimmune encephalomyelitis Immune tolerance Microparticles poly (Lactic-co-glycolic acid)
Online Access:	https://ijaai.tums.ac.ir/index.php/ijaai/article/view/890

Similar Items

Myelin oligodendrocyte glycoprotein encephalomyelitis: An unusual cause of blindness
by: Nimrat Sandhu, et al.
Published: (2022-01-01)

Prophylactic and Therapeutic Effects of MOG-Conjugated PLGA Nanoparticles in C57Bl/6 Mouse Model of Multiple Sclerosis
by: Mehrdad Gholamzad, et al.
Published: (2021-06-01)

Recurrent myelin oligodendrocyte glycoprotein⁃IgG⁃associated optic neuritis⁃encephalomyelitis: one case report
by: Jing SHA, et al.
Published: (2020-10-01)

Seizure and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis in a Retrospective Cohort of Chinese Patients
by: Xiaonan Zhong, et al.
Published: (2019-04-01)

Clinical and Neuroimaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein
by: Min Zhang, et al.
Published: (2020-11-01)

The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis
by: Jie Xu, et al.
Published: (2021-05-01)

PLGA-Based Microparticles for the Sustained Release of BMP-2
by: Maria A. Woodruff, et al.
Published: (2011-03-01)

Transient myelin oligodendrocyte glycoprotein antibody-positive acute disseminated encephalomyelitis following influenza A infection: A rare case
by: Prashant Nasa, et al.
Published: (2021-01-01)

Clinical and Magnetic Resonance Imaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein
by: Meifang Lei, et al.
Published: (2022-05-01)

Multichamber PLGA Microparticles with Enhanced Monodispersity and Encapsulation Efficiency Fabricated by a Batch‐Microfluidic Hybrid Approach
by: Sunghak Choi, et al.
Published: (2023-10-01)

Rational Design and Synthesis of Altered Peptide Ligands based on Human Myelin Oligodendrocyte Glycoprotein 35–55 Epitope: Inhibition of Chronic Experimental Autoimmune Encephalomyelitis in Mice
by: Theodore Tselios, et al.
Published: (2014-11-01)

Evaluation of IL-17 Serum Level, Brain Inflammation and Demyelination in Experimental Autoimmune Encephalomyelitis C57BL/6 Mice Model with Different Doses of Myelin Oligodendrocyte Glycoprotein
by: Mohammad Mehdi Ghorbani, et al.
Published: (2019-06-01)

Mucin-Grafted Polyethylene Glycol Microparticles Enable Oral Insulin Delivery for Improving Diabetic Treatment
by: Momoh A. Mumuni, et al.
Published: (2020-04-01)

Anaesthetic concerns in pregnancy associated with myelin oligodendrocyte glycoprotein encephalomyelitis
by: Aswini Kuberan, et al.
Published: (2022-01-01)

Oral Administration of Myelin Oligodendrocyte Glycoprotein Attenuates Experimental Autoimmune Encephalomyelitis through Induction of Th2/Treg Cells and Suppression of Th1/Th17 Immune Responses
by: Dariush Haghmorad, et al.
Published: (2022-11-01)

Myelin oligodendrocyte glycoprotein antibody-associated disease manifesting as intractable fever managed by bromocriptine: a case report
by: Jin San Lee, et al.
Published: (2023-06-01)

Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype In Vitro and Inhibits Type 1 Diabetes-Specific Autoreactive T Cell Responses
by: Maigan A. Brusko, et al.
Published: (2020-10-01)

Myelin oligodendrocyte glycoprotein antibody-associated disorders: clinical spectrum, diagnostic evaluation, and treatment options
by: Yun-Jin Lee, et al.
Published: (2021-03-01)

Pediatric acute disseminated encephalomyelitis associated with myelin oligodendrocyte glycoprotein antibodies
by: Redžek-Mudrinić Tatjana, et al.
Published: (2022-01-01)

Characterization of Asparagine Deamidation in Immunodominant Myelin Oligodendrocyte Glycoprotein Peptide Potential Immunotherapy for the Treatment of Multiple Sclerosis
by: Maria-Eleni Androutsou, et al.
Published: (2020-10-01)

Disulfiram-loaded porous PLGA microparticle for inhibiting the proliferation and migration of non-small-cell lung cancer
by: Wang C, et al.
Published: (2017-01-01)

SYNTHESIS AND CHARACTERIZATION OF POLY(D,L-LACTIC-CO-GLYCOLIC)ACID MICROPARTICLES LOADED BY DIPHTHERIA TOXOID
by: T. O. Chudina, et al.
Published: (2018-04-01)

Integration of Hydrogel Microparticles With Three-Dimensional Liver Progenitor Cell Spheroids
by: Stefan D. Gentile, et al.
Published: (2020-07-01)

A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis
by: Laura Calvo-Barreiro, et al.
Published: (2020-04-01)

A case of anti-myelin oligodendrocyte glycoprotein (MOG)-immunoglobulin G (IgG) associated disorder (MOGAD) with clinical manifestations of acute disseminated encephalomyelitis: Secondary to mycoplasma pneumoniae infection
by: Xiangui Huang, et al.
Published: (2023-02-01)

Acute Disseminated Encephalomyelitis with Measles
by: Ishrat Jahan, et al.
Published: (2013-01-01)

Characterization of Magnetic Polymeric Microparticles
by: Kazım Köse
Published: (2016-08-01)

Oligodendrocyte-specific Argonaute profiling identifies microRNAs associated with experimental autoimmune encephalomyelitis
by: Qin Ma, et al.
Published: (2020-10-01)

Fabrication of PEG-PLGA Microparticles with Tunable Sizes for Controlled Drug Release Application
by: Paul Nana Kwame Sagoe, et al.
Published: (2023-09-01)

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
by: Sven Jarius, et al.
Published: (2020-09-01)

SYNTHESIS AND CHARACTERIZATION OF POLY(LACTIC-CO-GLYCOLIC-ACID) MICROPARTICLES LOADED WITH FOOT-AND-MOUTH DISEASE VIRUS 40–60 SYNTHETIC PEPTIDE
by: Z. Mustafaeva
Published: (2017-05-01)

Clinical spectrum of myelin oligodendrocyte glycoprotein antibody-associated disease in Brazil: a single-center experience
by: Katharina Messias, et al.
Published: (2023-11-01)

Immunomodulatory and neuroprotective mechanisms of Huangqi glycoprotein treatment in experimental autoimmune encephalomyelitis
by: Yanxia Xing, et al.
Published: (2019-06-01)

A Case of Measles with Encephalomyelitis
by: Ali Irfan Baran, et al.
Published: (2020-09-01)

Recognition of a high affinity MHC class I-restricted epitope of myelin oligodendrocyte glycoprotein by CD8+ T cells derived from autoantigen-deficient mice.
by: Melanie D Leech, et al.
Published: (2011-05-01)

Drug release from PLGA microparticles can be slowed down by a surrounding hydrogel
by: L.A. Lefol, et al.
Published: (2023-12-01)

Myelin oligodendrocyte glycoprotein antibodies in neurological disease
by: Reindl, M, et al.
Published: (2018)

Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease
by: Osman Corbali, et al.
Published: (2023-02-01)

Myelin-Oligodendrocyte Glycoprotein Antibodies Spectrum Disorders
by: Masoud Etemadifar, et al.
Published: (2017-10-01)

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients
by: Sven Jarius, et al.
Published: (2020-09-01)